DK0535001T3 - Komposit molekylsystem til kontra-eskalativ terapi af virale infektioner - Google Patents

Komposit molekylsystem til kontra-eskalativ terapi af virale infektioner

Info

Publication number
DK0535001T3
DK0535001T3 DK91909678.4T DK91909678T DK0535001T3 DK 0535001 T3 DK0535001 T3 DK 0535001T3 DK 91909678 T DK91909678 T DK 91909678T DK 0535001 T3 DK0535001 T3 DK 0535001T3
Authority
DK
Denmark
Prior art keywords
wood
resultant
units
preparing
separating
Prior art date
Application number
DK91909678.4T
Other languages
English (en)
Inventor
Chantal Mach
Original Assignee
Chantal Mach
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chantal Mach filed Critical Chantal Mach
Application granted granted Critical
Publication of DK0535001T3 publication Critical patent/DK0535001T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK91909678.4T 1990-05-27 1991-05-27 Komposit molekylsystem til kontra-eskalativ terapi af virale infektioner DK0535001T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4017091A DE4017091A1 (de) 1990-05-27 1990-05-27 Molekuelverbundsystem zur kontra-eskalativen therapie viraler infektionskrankheiten

Publications (1)

Publication Number Publication Date
DK0535001T3 true DK0535001T3 (da) 1995-02-20

Family

ID=6407309

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91909678.4T DK0535001T3 (da) 1990-05-27 1991-05-27 Komposit molekylsystem til kontra-eskalativ terapi af virale infektioner

Country Status (17)

Country Link
US (2) US5554596A (da)
EP (1) EP0535001B1 (da)
JP (1) JP2905289B2 (da)
AT (1) ATE110275T1 (da)
AU (1) AU663684B2 (da)
BG (1) BG61154B1 (da)
CA (1) CA2084093C (da)
DE (2) DE4017091A1 (da)
DK (1) DK0535001T3 (da)
ES (1) ES2065034T3 (da)
FI (1) FI925363A (da)
HU (2) HUT68910A (da)
NO (1) NO306049B1 (da)
PL (1) PL168266B1 (da)
RO (1) RO113430B1 (da)
RU (1) RU2104016C1 (da)
WO (1) WO1991018616A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355684B1 (en) 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
US6348503B1 (en) 1996-02-12 2002-02-19 Meryl J. Squires Method and topical treatment composition for herpesvirus hominis
US6350784B1 (en) * 1996-02-12 2002-02-26 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
DE4236346A1 (de) * 1992-10-28 1994-05-05 Chantal Dr Mach Wirkstoffgruppe, Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE4316347C1 (de) * 1993-02-26 1994-08-18 Ina Dr Levi Verfahren zur Herstellung einer pharmazeutischen Zubereitung und Verwendung derselben zur Behandlung bestimmter Erkrankungen
DE4415087A1 (de) * 1994-04-29 1995-11-09 Zschiegner Hans Joachim Dr Mittel als Wirkstoffe bzw. Wirkstoffgemische zur Anwendung in der Balneotherapie, Gesundheitspflege und Kosmetik und Verfahren zur Herstellung pharmazeutischer Erzeugnisse sowie Verfahren zu ihrer Anwendung
DE4417254A1 (de) * 1994-05-17 1995-11-23 Zschiegner Hans Joachim Dr Mittel als Wirkstoffe bzw. Wirkstoffgemische für Tierarzneimittel, Tiergesundheitspflegemittel, Medizinalfuttermittel, Ergotropika und zur Anwendung in der Veterinärhygiene sowie Verfahren zur Herstellung der Mittel und pharmazeutischer Erzeugnisse und Methoden ihrer Anwendung
FR2731162B1 (fr) * 1995-03-01 1997-04-11 Oreal Procede d'extraction d'au moins un actif a partir de cellules vegetales indifferenciees
US20090191288A1 (en) * 1996-02-12 2009-07-30 Squires Meryl J Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases
FR2757046B1 (fr) * 1996-12-16 1999-03-05 Dior Christian Parfums Utilisation d'un extrait de resine d'okoume, dans les domaines cosmetique et pharmaceutique, notamment dermatologiques
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
RU2141335C1 (ru) * 1998-12-30 1999-11-20 Общество с ограниченной ответственностью "Лигфарм" Противоопухолевое средство "олипифат" и способ его получения
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
RU2172176C1 (ru) * 2000-06-19 2001-08-20 Общество с ограниченной ответственностью "Нобель" Способ получения противовирусного средства
US6866875B2 (en) * 2001-09-26 2005-03-15 Tampa Bay Research Institute Pine cone extracts and uses thereof
US7838046B2 (en) * 2001-09-26 2010-11-23 Tampa Bay Research Institute Plant extracts and uses thereof
US6703053B2 (en) * 2001-10-24 2004-03-09 Tampa Bay Research Institute Anti-HSV agent for inhibiting replication of HSV-1 and HSV-2 and method of producing a substance having anti-HSV activity
EP1711192B1 (en) * 2003-12-24 2013-12-04 Ramot at Tel-Aviv University Ltd. Antiviral preparations obtained from a natural cinnamon extract
RU2401117C1 (ru) * 2009-04-06 2010-10-10 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Средство для профилактики гриппа и острых респираторных заболеваний
JP2010273569A (ja) * 2009-05-26 2010-12-09 Wasaburo Sato メタボリックシンドローム改善作用を有する飲料及びサプリメント
US20100303935A1 (en) * 2009-05-29 2010-12-02 Squires Meryl J Medicinal Composition

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185097A (en) * 1978-01-09 1980-01-22 A. H. Robins Company, Inc. Method of combating Herpes simplex viruses with lignosulfonates
JPS54154507A (en) * 1978-05-22 1979-12-05 Eisai Co Ltd Inactivating agents for hbs anitgen
EP0035586B1 (de) * 1980-03-12 1984-06-13 Walter Dr. Dipl.-Phys. Mach Neuer biochemischer Wirkstoff, Verfahren zu seiner Herstellung und diesen Wirkstoff enthaltende pharmazeutische Zubereitung
JPS5939411B2 (ja) * 1980-12-24 1984-09-22 野田食菌工業株式会社 抗動物ウイルス剤
JPS57130919A (en) * 1981-02-06 1982-08-13 Eisai Co Ltd Lignin-containing virucide
DE3206911A1 (de) * 1982-02-26 1983-09-15 Lohmann Tierernährung GmbH, 2190 Cuxhaven Biochemischer wirkstoff, dessen herstellung und diesen wirkstoff enthaltendes mittel
DE3707909A1 (de) * 1987-03-12 1988-09-22 Ruetgerswerke Ag Niedermolekulare alkalihuminate, verfahren zu ihrer herstellung und verwendung
US4985249A (en) * 1987-06-26 1991-01-15 Hiroshi Sakagami Anti-HIV agents
US4988799A (en) * 1987-08-11 1991-01-29 Daishowa Chemicals Inc. Lignosulfonate based pharmacologic agent with anti-coagulant and anti-thrombotic activity
US4935239A (en) * 1988-04-12 1990-06-19 Sanyo-Kokusaku Pulp Co., Ltd. Composition for antiviral medicines
JP2602715B2 (ja) * 1988-04-12 1997-04-23 日本製紙 株式会社 抗ウィルス性医薬用組成物
CA1335259C (en) * 1989-03-31 1995-04-18 Makoto Machida Composition of spent liquor from pulping process for antiviral medicine
JPH02262524A (ja) * 1989-03-31 1990-10-25 Shozo Toda エイズウイルス増殖抑制剤
JPH02286623A (ja) * 1989-04-27 1990-11-26 Noda Shiyokukin Kogyo Kk 抗ウイルス物質及びその製法
JPH03120223A (ja) * 1989-10-04 1991-05-22 Sanyo Kokusaku Pulp Co Ltd 抗ウイルス性医薬用組成物
JP2923660B2 (ja) * 1990-01-06 1999-07-26 宏 坂上 ウイルス感染防止剤
JP2938916B2 (ja) * 1990-01-10 1999-08-25 日本ケミカルリサーチ株式会社 ヘルペスウィルスの増殖阻害および潜伏感染後の再発阻止剤

Also Published As

Publication number Publication date
US5554596A (en) 1996-09-10
HU9203747D0 (en) 1993-03-29
US5698524A (en) 1997-12-16
BG61154B1 (bg) 1997-01-31
NO924575D0 (no) 1992-11-26
DE59102660D1 (de) 1994-09-29
AU7892891A (en) 1991-12-31
WO1991018616A1 (de) 1991-12-12
CA2084093C (en) 2002-10-22
RU2104016C1 (ru) 1998-02-10
NO924575L (no) 1993-01-12
HUT68910A (en) 1995-08-28
AU663684B2 (en) 1995-10-19
JPH05507270A (ja) 1993-10-21
JP2905289B2 (ja) 1999-06-14
FI925363A0 (fi) 1992-11-25
EP0535001A1 (de) 1993-04-07
ATE110275T1 (de) 1994-09-15
NO306049B1 (no) 1999-09-13
EP0535001B1 (de) 1994-08-24
ES2065034T3 (es) 1995-02-01
DE4017091A1 (de) 1991-11-28
FI925363A (fi) 1992-11-25
PL168266B1 (pl) 1996-01-31
RO113430B1 (ro) 1998-07-30
CA2084093A1 (en) 1991-11-28
HU211541A9 (en) 1995-12-28
BG97122A (bg) 1993-12-24

Similar Documents

Publication Publication Date Title
DK0535001T3 (da) Komposit molekylsystem til kontra-eskalativ terapi af virale infektioner
RU92016546A (ru) Группа активных веществ для восстановительной химиотерапии
PT1192167E (pt) Complexo contendo substancias de lenhano fenolicas e alifaticas a partir do linho e processo para preparacao
Conti et al. Membrane carbohydrate requirement for rabies virus binding to chicken embryo related cells
Kleinschmidt et al. Investigations on interferon induced by statolon
GB2132914B (en) Peritoneal dialysis solutions and preparation thereof
FR2570081B1 (fr) Polysaccharides membranaires utiles notamment comme medicament et procede pour leur preparation
DE2963261D1 (en) Process for the growth of baker's yeast on acid whey
GB929679A (en) Improvements in and relating to resinous compositions
CA1339308C (en) Polysaccharides and antiviral drug containing polysaccharides as active ingredient
EP0491114B1 (en) A process for preparing new non-covalent polysaccharide-protein associations having pharmacological activity
AU5257490A (en) Process of preparing a tea product
DE59310192D1 (de) Ligninpolymerzusammensetzung zur Behandlung von Hautproblemen
EP0067000B1 (en) Production of a nitrogen-containing polysaccharide having antitumour activity
US4456597A (en) Interferon inducer, a process for producing the same and pharmaceutical composition containing the same
ES476703A1 (es) Procedimiento para preparar una heterovacuna para el trata -miento terapeutico del sindrome de los triconomas.
CA1202585A (en) Process for preparing substance having carcinostatic and immunostimulating activity
KR920006008A (ko) 골(骨) 형성 촉진 물질의 제조법
JPH0825897B2 (ja) 抗ウイルス剤
Shetlar et al. The effects of parathyroid extract upon incorporation of 1-14C-glucosamine into bone
JPS568686A (en) Preparation of galactose oxidase
GB901433A (en) Pulpy kidney disease/tetanus/lamb dysentery vaccine
CN111012907A (zh) 一种抗山羊副流感的饲料添加剂制备方法及应用
SU1725904A1 (ru) Способ получени бруцеллезной вакцины из штамма 82
Mohammed Cellular immunity in tuberculous patients before and 3-months after antituberculous chemotherapy with and without Immunostimulant" Levamisole"